Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Finch Therapeutics Group Inc (NQ: FNCH )

2.740 +0.020 (+0.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 902,347
Open 2.820
Bid (Size) 1.510 (1)
Ask (Size) 2.770 (1)
Prev. Close 2.720
Today's Range 2.670 - 2.900
52wk Range 1.712 - 17.39
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares rose 9.4% to $0.81 during Thursday's after-market session. The market value of their outstanding shares is at $2.8 million. 
Via Benzinga
Acurx Pharmaceuticals Is Under The Radar, That’s Excellent News For Investors Wanting Exposure To Billion Dollar CDI Treatment Market ($ACXP)
Via AB Newswire
Exposures Product Safety

Performance

YTD
-73.83%
-73.83%
1 Month
+30.48%
+30.48%
3 Month
-46.80%
-46.80%
6 Month
-73.93%
-73.93%
1 Year
-81.40%
-81.40%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stock Market Recap: This Week’s 5 Top Stories
Via InvestorPlace
Finch Therapeutics Cuts 20% Workforce, Realigns Focus On C. Diff, Autism Programs
Via Benzinga
70 Biggest Movers From Friday
Via Benzinga
Is ROKU Stock a Buy After Earnings? 4 Analysts Weigh In on Roku.
Via InvestorPlace
48 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Is Finch Therapeutics (FNCH) Stock Up 30% Today?
Via InvestorPlace
Peering Into Finch Therapeutics Group's Recent Short Interest
Via Benzinga
Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points
Via Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
28 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
U.S. FDA removes Clinical Hold on Finch's investigational new drug (IND) application for CP101
Via Benzinga
Finch Therapeutics Group Earnings Perspective: Return On Capital Employed
Via Benzinga
Acurx Pharmaceuticals Stands As Front-Line CDI Treatment Contender After Pfizer Misses Primary Endpoint In CDI Drug Trial (NASDAQ: ACXP)
Via AB Newswire
Exposures Product Safety
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
See Why Did Finch Therapeutics Halt Enrolment In Late-Stage C. Difficile Infection Trial
Via Benzinga
The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
36 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
54 Biggest Movers From Thursday
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.